CN Patent

CN113712977A — 一种克立硼罗外用制剂其制备方法及用途

Assigned to Nanjing Dili Pharmaceutical Technology Co ltd · Expires 2021-11-30 · 4y expired

What this patent protects

本发明涉及克立硼罗一种新的给药途径，更具体地说，涉及克立硼罗外用制剂、其制备方法及在制备治疗皮肤病的药物中的用途，属于医药技术领域。

USPTO Abstract

本发明涉及克立硼罗一种新的给药途径，更具体地说，涉及克立硼罗外用制剂、其制备方法及在制备治疗皮肤病的药物中的用途，属于医药技术领域。

Drugs covered by this patent

Patent Metadata

Patent number
CN113712977A
Jurisdiction
CN
Classification
—
Expires
2021-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Dili Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.